Correction: LabTech launches MicroStreak in US

By ALS staff
Friday, 13 June, 2008

In our online story LabTech launches MicroStreak in the US on June 11, we incorrectly stated that LabTech Systems had received royalties from sales.

The company is anticipating royalties but they have not been received yet. LabTech Systems has instead received licence payments of $4.9 million to date from licencee bioMerieux, and is entitled to receive up to a total of $11.2 million.

The original story has been corrected. We apologise for the error.

Related News

Quitting smoking increases life expectancy even for seniors

Although the benefits of quitting smoking diminish with age, there are still substantial gains...

Stem cell transplants treat blindness in mini pigs

Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...

Sugary drinks raise cardiovascular disease risk, but occasional sweets don't

Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd